ResearcherHarvard UniversityActive in the last 2 years
Alice A. Lee
Matched on ORCID iD 0000-0002-5241-1878; OpenAlex author ID A5101835429. Sources: OpenAlex.
Their work
- Papers
- 7
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 48
2022: 1 paper · 2023: 4 papers · 2024: none · 2025: 1 paper · 2026: 1 paper
Papers 7
- Outcomes of pancreatic cancer surveillance among high-risk individuals at a tertiary care academic center. Co-author DOI 10.1016/j.pan.2026.06.006↗
- Suboptimal adherence to surveillance in high-risk individuals for pancreatic cancer at a tertiary care academic center: Lessons from real-world surveillance pa… Co-author DOI 10.1016/j.pan.2025.05.002↗
- Pancreatic cancer is associated with medication changes prior to clinical diagnosis. Co-author DOI 10.1038/s41467-023-38088-2↗
- Adipose tissue and skeletal muscle wasting precede clinical diagnosis of pancreatic cancer. Co-author DOI 10.1038/s41467-023-40024-3↗
- Sex-Specific Associations between Adiponectin and Leptin Signaling and Pancreatic Cancer Survival. Co-author DOI 10.1158/1055-9965.epi-23-0505↗
- Helicobacter pylori Seropositivity, ABO Blood Type, and Pancreatic Cancer Risk From 5 Prospective Cohorts. Co-author DOI 10.14309/ctg.0000000000000573↗
- The age-dependent association of risk factors with pancreatic cancer. Co-author DOI 10.1016/j.annonc.2022.03.276↗
Closest collaborators
The 25 strongest of 48 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Ana Babić · 5 shared papers, 2022–2023 · strength 0.66
- Paper Pancreatic cancer is associated with medication changes prior to clinical diagnosis. DOI 10.1038/s41467-023-38088-2↗
- Paper Sex-Specific Associations between Adiponectin and Leptin Signaling and Pancreatic Cancer Survival. DOI 10.1158/1055-9965.epi-23-0505↗
- Paper Helicobacter pylori Seropositivity, ABO Blood Type, and Pancreatic Cancer Risk From 5 Prospective Cohorts. DOI 10.14309/ctg.0000000000000573↗
- Chen Yuan · 5 shared papers, 2022–2023 · strength 0.66
- Paper Pancreatic cancer is associated with medication changes prior to clinical diagnosis. DOI 10.1038/s41467-023-38088-2↗
- Paper Sex-Specific Associations between Adiponectin and Leptin Signaling and Pancreatic Cancer Survival. DOI 10.1158/1055-9965.epi-23-0505↗
- Paper Helicobacter pylori Seropositivity, ABO Blood Type, and Pancreatic Cancer Risk From 5 Prospective Cohorts. DOI 10.14309/ctg.0000000000000573↗
- Kimmie Ng · 5 shared papers, 2022–2023 · strength 0.66
- Paper Pancreatic cancer is associated with medication changes prior to clinical diagnosis. DOI 10.1038/s41467-023-38088-2↗
- Paper Sex-Specific Associations between Adiponectin and Leptin Signaling and Pancreatic Cancer Survival. DOI 10.1158/1055-9965.epi-23-0505↗
- Paper Helicobacter pylori Seropositivity, ABO Blood Type, and Pancreatic Cancer Risk From 5 Prospective Cohorts. DOI 10.14309/ctg.0000000000000573↗
- Qiao-Li Wang Wang · 5 shared papers, 2022–2023 · strength 0.66
- Paper Pancreatic cancer is associated with medication changes prior to clinical diagnosis. DOI 10.1038/s41467-023-38088-2↗
- Paper Sex-Specific Associations between Adiponectin and Leptin Signaling and Pancreatic Cancer Survival. DOI 10.1158/1055-9965.epi-23-0505↗
- Paper Helicobacter pylori Seropositivity, ABO Blood Type, and Pancreatic Cancer Risk From 5 Prospective Cohorts. DOI 10.14309/ctg.0000000000000573↗
- Brian Matthew Wolpin · 5 shared papers, 2022–2023 · strength 0.66
- Paper Pancreatic cancer is associated with medication changes prior to clinical diagnosis. DOI 10.1038/s41467-023-38088-2↗
- Paper Sex-Specific Associations between Adiponectin and Leptin Signaling and Pancreatic Cancer Survival. DOI 10.1158/1055-9965.epi-23-0505↗
- Paper Helicobacter pylori Seropositivity, ABO Blood Type, and Pancreatic Cancer Risk From 5 Prospective Cohorts. DOI 10.14309/ctg.0000000000000573↗
- Walter Gwang-Up Park · 2 shared papers, 2025–2026 · strength 0.63
- Paper Suboptimal adherence to surveillance in high-risk individuals for pancreatic cancer at a tertiary care academic center:… DOI 10.1016/j.pan.2025.05.002↗
- Paper Outcomes of pancreatic cancer surveillance among high-risk individuals at a tertiary care academic center. DOI 10.1016/j.pan.2026.06.006↗
- Edward L. Giovannucci · 4 shared papers, 2022–2023 · strength 0.53
- Paper Pancreatic cancer is associated with medication changes prior to clinical diagnosis. DOI 10.1038/s41467-023-38088-2↗
- Paper Sex-Specific Associations between Adiponectin and Leptin Signaling and Pancreatic Cancer Survival. DOI 10.1158/1055-9965.epi-23-0505↗
- Paper Helicobacter pylori Seropositivity, ABO Blood Type, and Pancreatic Cancer Risk From 5 Prospective Cohorts. DOI 10.14309/ctg.0000000000000573↗
- Peter Kraft · 4 shared papers, 2022–2023 · strength 0.53
- Paper Pancreatic cancer is associated with medication changes prior to clinical diagnosis. DOI 10.1038/s41467-023-38088-2↗
- Paper Sex-Specific Associations between Adiponectin and Leptin Signaling and Pancreatic Cancer Survival. DOI 10.1158/1055-9965.epi-23-0505↗
- Paper Helicobacter pylori Seropositivity, ABO Blood Type, and Pancreatic Cancer Risk From 5 Prospective Cohorts. DOI 10.14309/ctg.0000000000000573↗
- Jonathan Andrew Nowak · 3 shared papers, 2023 · strength 0.42
- Paper Pancreatic cancer is associated with medication changes prior to clinical diagnosis. DOI 10.1038/s41467-023-38088-2↗
- Paper Helicobacter pylori Seropositivity, ABO Blood Type, and Pancreatic Cancer Risk From 5 Prospective Cohorts. DOI 10.14309/ctg.0000000000000573↗
- Paper Adipose tissue and skeletal muscle wasting precede clinical diagnosis of pancreatic cancer. DOI 10.1038/s41467-023-40024-3↗
- Kimberly J. Perez · 3 shared papers, 2022–2023 · strength 0.39
- Paper Pancreatic cancer is associated with medication changes prior to clinical diagnosis. DOI 10.1038/s41467-023-38088-2↗
- Paper Helicobacter pylori Seropositivity, ABO Blood Type, and Pancreatic Cancer Risk From 5 Prospective Cohorts. DOI 10.14309/ctg.0000000000000573↗
- Paper The age-dependent association of risk factors with pancreatic cancer. DOI 10.1016/j.annonc.2022.03.276↗
- Pradeep K. Siddappa · 1 shared paper, 2026 · strength 0.30
- Allison W. Kurian · 1 shared paper, 2026 · strength 0.30
- Michael Hayden Rosenthal · 2 shared papers, 2023 · strength 0.28
- Jihye Kim · 2 shared papers, 2023 · strength 0.28
- JoAnn E. Manson · 2 shared papers, 2023 · strength 0.28
- Jean Wactawski‐Wende · 2 shared papers, 2023 · strength 0.28
- Charles S. Fuchs · 2 shared papers, 2023 · strength 0.28
- Stephen K. Van Den Eeden · 2 shared papers, 2022–2023 · strength 0.23
- Yin Zhang · 1 shared paper, 2023 · strength 0.15
- Jesper Lagergren · 1 shared paper, 2023 · strength 0.15
- Chris Sander · 1 shared paper, 2023 · strength 0.15
- Fred K. Tabung · 1 shared paper, 2023 · strength 0.14
- Juhua Luo · 1 shared paper, 2023 · strength 0.14
- Leah H. Biller · 1 shared paper, 2023 · strength 0.13
- Khoschy Schawkat · 1 shared paper, 2023 · strength 0.13
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.